Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00773123

Enrollment

300

Registered

2008-10-16

Start date

2008-10-31

Completion date

2008-12-31

Last updated

2008-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma

Keywords

RT-View, Spectral domain OCT, Ganglion cell layer, RNFL, Visual field defect

Brief summary

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion cell layer thickness.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 90 Years

Healthy volunteers

Yes

Exclusion criteria

* Evidence of retinal disease * Neovascular glaucoma * Secondary glaucoma due to intraocular inflammation * Lens induced glaucoma * Tumor induced glaucoma

Design outcomes

Primary

Measure	Time frame
Ganglion cell layer thickness	1 month

Secondary

Measure	Time frame
Visual field defect	1 month

Countries

South Korea

Contacts

Primary ContactChan Yun Kim, MD,PhD

kangeye@hotmail.com82-2-2228-3570

Backup ContactSung Yong Kang, MD

kangeye@yuhs.ac82-2-2228-3570

Outcome results